Listed

John Wiley & Sons, Inc.: Form 10-Q for the period ended Jan 31, 2024

Filed with the SEC on Mar 8, 2024 and accepted by EDGAR at Mar 8, 2024, 11:08 ET.

Share

Management's discussion and analysis

As filed, 72,355 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The information in our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read together with our Condensed Consolidated Financial Statements and related notes set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q, our MD&A set forth in Item 7 of Part II of our 2023 Form 10-K and our Consolidated Financial Statements and related notes set forth in Item 8 of Part II of our 2023 Form 10-K. See Part II, Item 1A, “Risk Factors,” below and “Cautionary Notice Regarding Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995,” above, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in thousands, except per share amounts or where otherwise noted. When we cross-reference to a “Note,” we are referring to our “Notes to Unaudited Condensed Consolidated Financial Statements,” unless the context indicates otherwise.

OVERVIEW

Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Wiley is a predominantly digital company with over 80% of Wiley's revenue for fiscal year 2023 generated by digital products excluding the Held for Sale or Sold segment revenue. For fiscal year 2023, 50% of revenue excluding the Held for Sale or Sold segment revenue is recurring which includes revenue that is contractually obligated or set to recur with a high degree of certainty.

On June 1, 2023, Wiley’s Board of Directors approved a plan to divest certain businesses that we determined are non-core businesses. Those businesses are University Services, Wiley Edge, and CrossKnowledge. On January 1, 2024 we completed the sale of University Services, and on January 8, 2024 we signed an agreement to sell Wiley Edge. We expect to complete the sale of Wiley Edge and CrossKnowledge by the first quarter of fiscal year 2025. As a result of these planned divestitures, in the three months ended July 31, 2023 we reorganized our segments and our new structure consists of three reportable segments which includes Research (no change), Learning, and Held for Sale or Sold, as well as a Corporate expense category (no change). The operations of University Services, Wiley Edge, and CrossKnowledge are reported in the Held for Sale or Sold segment until sold. Prior period segment results have been revised to the new segment presentation. There were no changes to our consolidated financial results.

  • Research is unchanged and includes the reporting lines of Research Publishing and Research Solutions;
  • Learning includes the Academic and Professional reporting lines and consists of publishing and related knowledge solutions;
  • Held for Sale or Sold includes businesses held-for-sale including Wiley Edge, and CrossKnowledge, as well as those sold in fiscal year 2024 which includes University Services, and Tuition Manager, and in fiscal year 2023 Test Prep and Advancement Courses.

Through the Research segment, we provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals.

Wiley’s business strategies are tightly aligned with solid growth trends, including ever-increasing global R&D spend leading to consistent growth in scientific research output, the transition to open research, and the increasing application of new knowledge into solutions to solve real world problems. These strategies include driving publishing output to meet the global demand for peer-reviewed research and expanding platform and service offerings for corporations and societies. Learning strategies include scaling high-value digital content, courseware, and assessments.

On January 1, 2024, we completed the sale of University Services pursuant to a Membership Interest and Asset Purchase Agreement with Academic Partnerships LLC, a Delaware limited liability company (Academic Partnerships), and Education Services Upper Holdings Corp., a Delaware corporation. The selling price for University Services at the date of sale had a fair value of $122.6 million, paid in the form of (i) an unsecured promissory note with an initial aggregate principal amount of $92.9 million (Seller Note), subject to customary working capital adjustments; (ii) $17.8 million of additional contingent consideration in the form of an earnout recorded at fair value based on revenue targets during each of the two fiscal years in the period from May 1, 2024 through April 30, 2026 (Earnout); and (iii) a number of common units of TVG-Academic Partnerships Holdings, LLC, the ultimate parent company of Academic Partnerships equal to 10% of the total common units outstanding at the date of sale valued at $11.9 million (TVG Investment). We have also entered into a transition services agreement to facilitate the transition of the divested business.

On January 8, 2024, we entered into a stock and asset purchase agreement (Purchase Agreement) with Inspirit Vulcan Bidco Limited, a private limited company incorporated in England & Wales (Inspirit), pursuant to which we agreed to sell our emerging talent and reskill training business, Wiley Edge (the Business), to Inspirit (the Transaction). We expect the Transaction to close in the first quarter of fiscal year 2025. The selling price for the Business includes total consideration of up to $62.2 million and will consist of: (i) $10 million in cash, (ii) $18.3 million in the form of a loan note to be issued by Inspirit, subject to a customary purchase price adjustment, including for working capital, and (iii) up to $33.9 million in the form of an earnout based on the gross profit generated by the Business relative to mutually agreed profit targets during each of the three fiscal years in the period beginning May 1, 2024 and ending April 30, 2027. The results of Wiley Edge will continue to be reported in our operating results in the Held for Sale or Sold segment until the sale is finalized. We will enter into a transition services agreement to facilitate the transition of the divested business.

RESULTS OF OPERATIONS – THREE MONTHS ENDED JANUARY 31, 2024

THIRD QUARTER SUMMARY

  • US GAAP Results: Consolidated Revenue of $460.7 million (-6%, compared with the prior year), Operating Loss of $46.4 million (+$20.6 million, compared with the prior year operating loss), and Diluted Loss per Share of $(2.08) (-$0.79, compared with the prior year diluted loss per share). US GAAP revenue decrease due to completed divestiture and declines in other held for sale businesses. US GAAP results impacted by goodwill impairment of $81.7 million, losses on sale of businesses and impairment charges related to assets held-for-sale of $52.4 million, and restructuring charges of $14.8 million.
  • Adjusted Results at Constant Currency (excluding Held for Sale or Sold segment results): Adjusted Revenue of $402.5 million (+1%, compared with the prior year), Adjusted EBITDA of $91.5 million (+1%, compared with the prior year), and Adjusted EPS of $0.59 (-27%, compared with the prior year).

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the three months ended January 31, 2024, decreased $30.7 million, or 6%, as compared with the prior year. On a constant currency basis, revenue decreased 7% as compared with the prior year. Excluding the revenues from the Held for Sale or Sold segment, Adjusted Revenue increased 1% on a constant currency basis.

Adjusted Revenue

Below is a reconciliation of our consolidated US GAAP Revenue to Non-GAAP Adjusted Revenue:

Three Months Ended January 31, 2024 2023
US GAAP Revenue, net $460,705 $491,368
Less: Held for Sale or Sold segment (1) (58,172) (94,525)
Non-GAAP Adjusted Revenue, net $402,533 $396,843

(1) Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the three months ended January 31, 2024, decreased $30.4 million, or 17%, as compared with the prior year. On a constant currency basis, cost of sales decreased 18% as compared with the prior year. This was primarily due to lower employee costs related to the Wiley Edge business and, to a lesser extent, lower marketing and employee costs for the University Services business. Excluding the cost of sales from the Held for Sale or Sold segment, cost of sales decreased 3% as compared with the prior year on a constant currency basis primarily due to lower print product costs, lower costs driven by the revenue decline in Research, partially offset by higher royalty costs in the Learning segment.

Operating and Administrative Expenses:

Operating and administrative expenses for the three months ended January 31, 2024, decreased $2.4 million, or 1% as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 2% as compared with the prior year primarily reflecting lower employment costs, a $3.7 million charge related to the settlement of a litigation mater related to consideration for a previous acquisition in the three months ended January 31, 2023, and professional fees, partially offset by higher depreciation due to the decision in the three months ended January 31, 2024 to discontinue the use of certain capitalized software resulting in an impairment of $6.4 million and, to a lesser extent, higher technology related costs. Excluding operating and administrative expenses from the Held for Sale or Sold segment, expenses increased 3% on a constant currency basis.

Impairment of Goodwill:

We recorded an impairment of goodwill for the three months ended January 31, 2024 and 2023 of $81.7 million and $99.8 million, respectively. These charges are reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net Loss.

Fiscal Year 2024

As a result of signing the Purchase Agreement with Inspirit and the decrease in the fair value of the business, we tested the goodwill of the Wiley Edge reporting unit within the Held for Sale or Sold segment for impairment. We estimated the fair value of the reporting unit based on the terms and conditions in the Purchase Agreement which included a selling price that included $10 million in cash, $18.3 million in the form of a loan, a fair value estimate for the earnout, and an estimate for a working capital adjustment. We concluded that the fair value of the Wiley Edge reporting unit was below its carrying value, which resulted in a pretax noncash goodwill impairment of $81.7 million in the three months ended January 31, 2024. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net Loss.

See Note 12, “Goodwill and Intangible Assets” for more details on these charges.

Fiscal Year 2023

Due to the segment realignment in the third quarter of fiscal year 2023, we were required to test goodwill for impairment immediately before and after our segment realignment in accordance with applicable accounting standards. Prior to the realignment, we concluded that the fair value of the Education Services reporting unit was below its carrying value, which resulted in a pretax noncash goodwill impairment of $31.0 million in the three months ended January 31, 2023. Education Services was adversely impacted by market conditions and headwinds for online degree programs. This has led to a decline in projected student enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term, which adversely impacted forecasted revenue growth and operating cash flows. This was partially offset by projected growth in talent placements, partially due to expansion into new regions and the addition of new corporate clients, which are forecasted to have a positive impact on revenue growth and operating cash flows.

After the realignment, we concluded that the fair value of the University Services reporting unit within the Academic segment was below its carrying value, which resulted in an additional pretax noncash goodwill impairment of $68.8 million. University Services was adversely impacted by market conditions and headwinds for online degree programs, which lead to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows.

Restructuring and Related Charges:

Global Restructuring Program

In May 2022, the Company initiated a global program (Global Restructuring Program) to restructure and align our cost base with current and anticipated future market conditions, which was previously referred to as the Fiscal Year 2023 Restructuring Program. This program included severance related charges for the elimination of certain positions, the exit of certain leased office space, and the reduction of our occupancy at other facilities. Under this program, we reduced our real estate square footage occupancy by approximately 22%.

In the three months ended July 31, 2023, we expanded the scope of the program to include those actions that will focus Wiley on its leading global position in the development and application of new knowledge and drive greater profitability, growth, and cash flow. We will focus on our strongest and most profitable businesses and large market opportunities in Research and Learning, as well as streamline our organization and rightsize our cost structure to reflect these portfolio actions. As part of the Global Restructuring Program, we are further reducing our real estate square footage occupancy by approximately 13%.

Excluding actions related to the Held for Sale or Sold segment, we anticipate to yield annualized cost savings of approximately $65 million, with approximately $35 million of that to be realized this fiscal year from actions taken starting in fiscal year 2024.

For the three months ended January 31, 2024 and 2023, we recorded pretax restructuring charges of $14.4 million and $8.9 million, respectively, related to this program.

We anticipate ongoing severance related charges and facility-related costs associated with certain properties to result in additional restructuring charges in future periods.

See Note 9, “Restructuring and Related Charges” for more details on the Global Restructuring Program charges.

Business Optimization Program

For the three months ended January 31, 2024 and 2023, we recorded pretax restructuring charges of $0.4 million and credits of $(0.1) million, respectively, related to this program.

These charges and credits are reflected in Restructuring and related charges on our Unaudited Condensed Consolidated Statements of Net Loss.

For the impact of our restructuring programs on diluted loss per share, see the section below, “Diluted Loss per Share.”

Amortization of Intangible Assets:

Amortization of intangible assets was $13.5 million for the three months ended January 31, 2024, a decrease of $6.5 million, or 32%, as compared with the prior year. On a constant currency basis, amortization of intangible assets decreased 33% as compared with the prior year primarily due to the cessation of amortization for held-for-sale assets. See Note 3, “Acquisitions and Divestitures” for more details on these held-for-sale assets.

Operating Loss, Adjusted Operating Income (OI) and Adjusted EBITDA:

Our operating loss was $46.4 million for the three months ended January 31, 2024, compared with the prior year operating loss of $67.1 million. The decrease was primarily due to lower costs of sales, a lower goodwill impairment in the three months ended January 31, 2024 and, to a lesser extent, a decrease in the amortization of intangible assets. These were partially offset by a decrease in revenue and, to a lesser extent, an increase in restructuring charges.

Adjusted OI on a constant currency basis and excluding restructuring charges, impairment of goodwill, legal settlement, and the adjusted contribution to profit for the Held for Sale or Sold segment decreased 5% as compared with the prior year. The decrease in Adjusted OI was primarily due to an increase in operating and administrative expenses, partially offset by lower costs of sales, and an increase in Adjusted Revenue.

Adjusted EBITDA on a constant currency basis increased 1% as compared with the prior year primarily due to lower cost of sales, and an increase in Adjusted Revenue, partially offset by an increase in operating and administrative expense.

Adjusted OI

Below is a reconciliation of our consolidated US GAAP Operating Loss to Non-GAAP Adjusted OI:

Three Months Ended January 31, 2024 2023
US GAAP Operating Loss (46,411) (67,056)
Adjustments:
Restructuring and related charges 14,808 8,807
Impairment of goodwill 81,754 99,800
Legal settlement (1) — 3,671
Held for Sale or Sold segment Adjusted Contribution to Profit (2) (4,118) 3,565
Non-GAAP Adjusted OI $46,033 $48,787

(1) In the three months ended January 31, 2023, we settled a litigation matter related to consideration for a previous acquisition for $3.7 million.

(2) Our Adjusted OI excludes the impact of our Held for Sale or Sold segment adjusted contribution to profit.

46

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA:

Three Months Ended January 31, 2024 2023
Net Loss $(113,875) $(71,469)
Interest expense 13,321 11,521
Provision (benefit) for income taxes 1,579 (5,982)
Depreciation and amortization 45,474 52,442
Non-GAAP EBITDA (53,501) (13,488)
Impairment of goodwill 81,754 99,800
Legal settlement — 3,671
Restructuring and related charges 14,808 8,807
Foreign exchange gains, including the write off of certain cumulative translation adjustments (488) (421)
Losses on sale of businesses and impairment charges related to assets held-for-sale 52,404 —
Other expense (income), net 648 (705)
Held for Sale or Sold segment Adjusted EBITDA (1) (4,118) (7,325)
Non-GAAP Adjusted EBITDA $91,507 $90,339

(1) Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA.

Interest Expense:

Interest expense for the three months ended January 31, 2024, was $13.3 million compared with the prior year of $11.5 million. This increase was primarily due to a higher weighted average effective interest rate.

Foreign Exchange Transaction Gains:

Foreign exchange transaction gains of $0.5 million for the three months ended January 31, 2024 were primarily due to gains on our foreign currency denominated intercompany accounts receivable and payable balances, partially offset by losses on our third-party receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Foreign exchange transaction gains of $0.4 million for the three months ended January 31, 2023 were primarily due to gains on our foreign currency denominated intercompany accounts receivable and payables balances, partially offset by losses on our third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Losses on Sale of Businesses and Impairment Charges Related to Assets Held-For-Sale:

For the three months ended January 31, 2024, we recorded pretax losses on sale of businesses and impairment charges related to assets held-for-sale of $52.4 million.

As part of our ongoing initiatives to simplify our portfolio and focus our attention on core growth areas, we previously announced that we are divesting non-core businesses including University Services, Wiley Edge, and CrossKnowledge. These three businesses met the held-for-sale criteria in the first quarter of fiscal year 2024. We measured each disposal group at the lower of carrying value or fair value less cost to sell prior to its disposition.

On January 1, 2024 we completed the sale of University Services, and on January 8, 2024 we signed an agreement to sell Wiley Edge. We expect to complete the sale of Wiley Edge and CrossKnowledge by the first quarter of fiscal year 2025.

The pretax loss on the sale of University Services was $101.4 million after accounting for the assets sold, liabilities transferred upon sale, and transaction costs. Prior to the disposition, we had recorded a held-for-sale impairment of $75.4 million for University Services. This resulted in an additional loss of $26.0 million in the three months ended January 31, 2024. This additional pretax loss is included in Losses on sale of businesses and impairment charges related to assets held-for-sale in our Unaudited Condensed Consolidated Statements of Net Loss for the three months ended January 31, 2024.

As of January 31, 2024, Wiley Edge and CrossKnowledge continue to be reported as held-for-sale. We measured each disposal group at the lower of carrying value or fair value less cost to sell. In the three months ended January 31, 2024, we recorded a held-for-sale pretax impairment of $20.6 million and $5.8 million, respectively, related to Wiley Edge and CrossKnowledge. The additional impairment charges in the three months ended January 31, 2024 was due to subsequent changes in the fair value less cost to sell resulting from the continued progression of the selling processes and indications of changes in the expected consideration for the business, as well as changes in the carrying amount of the disposal group. Additional impairment charges related to all of our assets held-for-sale could be identified as we continue with the disposition process until completion of such actions.

See Note 3, “Acquisitions and Divestitures” for more details on the divestiture and the held-for-sale businesses.

Provision (Benefit) for Income Taxes:

Below is a reconciliation of our US GAAP Loss Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Three Months Ended January 31, 2024 2023
US GAAP Loss Before Taxes $(112,296) $(77,451)
Pretax Impact of Adjustments:
Impairment of goodwill 81,754 99,800
Legal settlement — 3,671
Restructuring and related charges 14,808 8,807
Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (2,128) (2,414)
Amortization of acquired intangible assets 13,580 21,042
Losses on sale of businesses and impairment charges related to assets held-for-sale 52,404 —
Held for Sale or Sold segment Adjusted Income Before Taxes (1) (4,120) (2,484)
Non-GAAP Adjusted Income Before Taxes $44,002 $50,971

(1) Our Adjusted Income Before Taxes excludes the Adjusted Income Before Taxes of our Held for Sale or Sold segment.

Below is a reconciliation of our US GAAP Income Tax Provision (Benefit) to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Three Months Ended January 31, 2024 2023
US GAAP Income Tax Provision (Benefit) $1,579 $(5,982)
Income Tax Impact of Adjustments (1):
Impairment of goodwill — 4,857
Legal settlement — 716
Restructuring and related charges 3,985 2,221
Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (742) (596)
Amortization of acquired intangible assets 1,152 4,591
Losses on sale of businesses and impairment charges related to assets held-for-sale 6,508 —
Held for Sale or Sold segment Adjusted Tax Provision (2) (1,252) (531)
Non-GAAP Adjusted Income Tax Provision $11,230 $5,276
US GAAP Effective Tax Rate (1.4)% 7.7%
Non-GAAP Adjusted Effective Tax Rate 25.5% 10.4%

(1) For the three months ended January 31, 2024, substantially all of the tax impact was from deferred taxes. For the three months ended January 31, 2023, the tax impact was $4.0 million from current taxes and $7.2 million from deferred taxes.

(2) Our Adjusted Income Tax Provision excludes the Adjusted Tax Provision of our Held for Sale or Sold segment.

Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to tax attributes. The US GAAP effective tax rate for the three months ended January 31, 2024, was (1.4)% compared to 7.7% for the three months ended January 31, 2023. The US GAAP effective tax rate for the three months ended January 31, 2024, was less than the US GAAP effective tax rate for the three months ended January 31, 2023 primarily due to losses on sale of businesses and impairment charges related to assets held-for-sale described in Note 3, "Acquisitions and Divestitures" which resulted in a deferred tax benefit, the impact of US tax incentives, and other discrete items offset by the mix of non-US income.

The Non-GAAP adjusted effective tax rate was 25.5% for the three months ended January 31, 2024, compared to 10.4% for the three months ended January 31, 2023. The increase in the Non-GAAP adjusted effective tax rate for the three months ended January 31, 2024, compared with the three months ended January 31, 2023, was primarily due to the mix of non-US income offset by tax incentives in the US.

Diluted Loss per Share:

Diluted loss per share for the three months ended January 31, 2024 was $(2.08) per share compared with loss per share of $(1.29) per share for the three months ended January 31, 2023. This decrease was primarily due to losses on the sale of businesses and impairment charges related to assets held-for-sale in the three months ended January 31, 2024 and, to a lesser extent, an income provision for the three months ended January 31, 2024 compared to a benefit in the prior year, partially offset by a lower operating loss in the three months ended January 31, 2024.

Below is a reconciliation of our US GAAP Loss per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below are presented in the section above, “Provision (Benefit) for Income Taxes.”

Three Months Ended January 31, 2024 2023
US GAAP Loss Per Share $(2.08) $(1.29)
Adjustments:
Impairment of goodwill 1.48 1.69
Legal settlement — 0.05
Restructuring and related charges 0.20 0.12
Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (0.03) (0.03)
Amortization of acquired intangible assets 0.22 0.29
Losses on sale of businesses and impairment charges related to assets held-for-sale 0.83 —
Held for Sale or Sold segment Adjusted Net Income (1) (0.05) (0.04)
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) 0.02 0.02
Non-GAAP Adjusted EPS $0.59 $0.81

(1) Our Adjusted EPS excludes the Adjusted Net Income of our Held for Sale or Sold segment.

(2) Represents the impact of using diluted weighted-average number of common shares outstanding (55.3 million shares and 56.1 million shares for the three months ended January 31, 2024 and 2023, respectively) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS decreased 27% primarily due to an increase in Adjusted Income Tax Provision and, to a lesser extent, a decrease in Adjusted Operating Income.

SEGMENT OPERATING RESULTS

RESEARCH Revenue: Three Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing $216,586 $213,720 1% 0%
Research Solutions 39,613 39,880 (1)% (1)%
Total Research Revenue 256,199 253,600 1% 0%
Cost of Sales 69,906 70,806 1% 2%
Operating Expenses 117,961 114,045 (3)% (2)%
Amortization of Intangible Assets 11,234 11,572 3% 4%
Adjusted Contribution to Profit 57,098 57,177 0% 0%
Depreciation and amortization 22,029 23,123 5% 6%
Adjusted EBITDA $79,127 $80,300 (1)% (2)%
Adjusted EBITDA Margin 30.9% 31.7%

Revenue:

Research revenue for the three months ended January 31, 2024 increased $2.6 million, or 1%, as compared with the prior year on a reported basis. On a constant currency basis, revenue was consistent as compared with the prior year. Research Publishing revenue was consistent on a constant currency basis as compared with the prior year primarily due to continued growth in our core open access publishing program and institutional models which includes both read-only subscriptions and read-and-publish transformational agreements, offset by the carryover of the Hindawi publishing disruption experienced in fiscal year 2023. Hindawi’s special issues program was suspended in the third quarter of fiscal year 2023 due to the presence in certain special issues of compromised articles. On a constant currency basis excluding Hindawi, Research Publishing revenue increased 2% as compared with the prior year. Research Solutions decreased 1% as compared with the prior year on a constant currency basis primarily due to continued market softness in our corporate offerings. On a constant currency basis excluding Hindawi, Research revenue increased 1% as compared with the prior year.

Open access article output growth was approximately 10% as compared with the prior year. Excluding Hindawi, open access article output growth was approximately 16% for the three months ended January 31, 2024.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 2% as compared with the prior year. This decrease was primarily due to higher editorial and marketing costs, partially offset by lower costs of sales due to revenue performance. Excluding Hindawi, Adjusted EBITDA decreased 1%.

INDEX

LEARNING Revenue: Three Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic $87,216 $82,822 5% 5%
Professional 59,118 60,421 (2)% (3)%
Total Learning Revenue 146,334 143,243 2% 2%
Cost of Sales 38,744 40,731 5% 5%
Operating Expenses 67,794 70,297 4% 4%
Amortization of Intangible Assets 2,283 2,347 3% 3%
Adjusted Contribution to Profit 37,513 29,868 26% 25%
Depreciation and amortization 13,812 14,490 5% 5%
Adjusted EBITDA $51,325 $44,358 16% 15%
Adjusted EBITDA Margin 35.1% 31.0%

Revenue:

Learning revenue increased $3.1 million, or 2%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 2% as compared with the prior year. This was primarily due to an increase in Academic from continued growth in digital courseware, digital content, and licensing, partially offset by a decrease in print book sales due to lower demand. Professional decreased due to lower print sales due to softness in business and technology publishing categories, partially offset by higher licensing revenue.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 15% as compared with the prior year. This increase was primarily due to revenue performance and product mix, and a decrease in operating expenses due to restructuring savings.

INDEX

HELD FOR SALE OR SOLD Three Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Held for Sale or Sold Revenue $58,172 $94,525 (38)% (39)%
Cost of Sales 35,012 62,514 44% 45%
Operating Expenses 19,042 29,527 36% 37%
Amortization of Intangible Assets — 6,049 # #
Adjusted Contribution to Profit 4,118 (3,565) # #
Depreciation and amortization — 10,890 # #
Adjusted EBITDA $4,118 $7,325 (44)% (45)%
Adjusted EBITDA Margin 7.1% 7.7%

# Not meaningful

Revenue:

Revenue for Held for Sale or Sold decreased $36.4 million, or 38%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 39% as compared with the prior year. This was due to a decrease in University Services revenue due to lower enrollments and the sale of the business on January 1, 2024, placement revenues and, to a lesser extent, the disposition of certain businesses in the fourth quarter of fiscal year 2023 and the first quarter of fiscal year 2024. For the three months ended January 31, 2024, placements declined 51% and enrollments declined 3%.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 45% as compared with the prior year. This decrease was primarily due to lower revenue, partially offset by placement savings, and lower marketing and employment costs in University Services due to restructuring actions and, to a lesser extent, the impact of the disposition of certain businesses in the fourth quarter of fiscal year 2023 and in fiscal year 2024.

CORPORATE EXPENSES Three Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Operating Expenses $48,578 $38,258 (27)% (26)%
Adjusted Contribution to Profit (48,578) (38,258) (27)% (26)%
Depreciation and amortization 9,633 3,939 # #
Adjusted EBITDA $(38,945) $(34,319) (13)% (13)%

# Not meaningful

On a constant currency basis, adjusted corporate expenses of $38.9 million on an Adjusted EBITDA basis increased 13% as compared with the prior year. This was primarily due to a lower incentive compensation accrual in the prior year.

RESULTS OF OPERATIONS – NINE MONTHS ENDED JANUARY 31, 2024

NINE MONTHS SUMMARY

  • US GAAP Results: Consolidated Revenue of $1,404.5 million (-6%, compared with the prior year), Operating Loss of $16.5 million (+$10.1 million, compared with the prior year operating loss), and Diluted Loss per Share of $(4.10) ($-3.18, compared with the prior year diluted loss per share). US GAAP results impacted by goodwill impairment of $108.4 million, losses on sale of businesses and impairment charges related to assets held-for-sale of $179.7 million, and restructuring charges of $52.0 million.
  • Adjusted Results at Constant Currency (excluding Held for Sale or Sold segment results): Adjusted Revenue of $1,176.3 million (-3%, compared with the prior year), Adjusted EBITDA of $243.6 million (-7%, compared with the prior year), and Adjusted EPS of $1.59 (-29%, compared with the prior year).

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the nine months ended January 31, 2024, decreased $89.2 million, or 6%, as compared with the prior year. On a constant currency basis, revenue decreased 7% as compared with the prior year. Excluding the revenues from the Held for Sale or Sold segment, Adjusted Revenue decreased 3% on a constant currency basis.

Adjusted Revenue

Below is a reconciliation of our consolidated US GAAP Revenue to Non-GAAP Adjusted Revenue:

Nine Months Ended January 31, 2024 2023
US GAAP Revenue, net $1,404,526 $1,493,773
Less: Held for Sale or Sold segment (1) (228,259) (291,362)
Non-GAAP Adjusted Revenue, net $1,176,267 $1,202,411

(1) Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the nine months ended January 31, 2024, decreased $62.0 million, or 12%, as compared with the prior year. On a constant currency basis, cost of sales decreased 13% as compared with the prior year. This was primarily due to lower employee costs related to the Wiley Edge business, and to a lesser extent, lower marketing and employee costs for the University Services business. In addition, lower amortization primarily due to the cessation of amortization for held-for-sale assets. Excluding the cost of sales from the Held for Sale or Sold segment, cost of sales decreased 3% on a constant currency basis, primarily due to a decrease in revenue.

Operating and Administrative Expenses:

Operating and administrative expenses for the nine months ended January 31, 2024, decreased $30.1 million, or 4%, as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 5% as compared with the prior year primarily reflecting lower employee costs associated with recent restructuring actions and, to a lesser extent, lower professional fees, travel and entertainment costs, and a $3.7 million charge related to the settlement of a litigation mater related to consideration for a previous acquisition in the three months ended January 31, 2023. These were partially offset by higher depreciation due to the decision in the three months ended January 31, 2024 to discontinue the use of certain capitalized software resulting in an impairment of $6.4 million, and higher technology related costs. Excluding operating and administrative expenses from the Held for Sale or Sold segment, operating and administrative expenses decreased 1% on a constant currency basis.

Impairment of Goodwill:

We recorded an impairment of goodwill in the nine months ended January 31, 2024 and 2023 of $108.4 million and $99.8 million, respectively. These charges are reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net Loss.

Fiscal Year 2024

As a result of signing the Purchase Agreement with Inspirit and the decrease in the fair value of the business, we tested the goodwill of the Wiley Edge reporting unit within the Held for Sale or Sold segment for impairment. We concluded that the fair value of the Wiley Edge reporting unit was below its carrying value, which resulted in a pretax noncash goodwill impairment of $81.7 million in the nine months ended January 31, 2024. See above for more details on these charges.

Due to the segment realignment in the first quarter of fiscal year 2024, we were required to test goodwill for impairment immediately before and after our segment realignment in accordance with applicable accounting standards. Prior to the realignment, we concluded that the fair value of the University Services reporting unit within the former Academic segment was below its carrying value, which resulted in a pretax noncash goodwill impairment of $11.4 million in the nine months ended January 31, 2024. University Services was adversely impacted by market conditions and headwinds for online degree programs, which lead to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows.

After the realignment, we concluded that the fair value of the CrossKnowledge reporting unit within the Held for Sale or Sold segment was below its carrying value, which resulted in a pretax noncash goodwill impairment of $15.3 million in the nine months ended January 31, 2024. CrossKnowledge was adversely impacted by a decline in the demand for its offerings, which have resulted in lower sales and a decline in average contract value, that adversely impacted forecasted revenue growth and operating cash flows.

See Note 12, "Goodwill and Intangible Assets" for details on these charges.

Fiscal year 2023

We recorded an impairment of goodwill for the nine months ended January 31, 2023 of $99.8 million. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net Loss. See above for more details on these charges.

Restructuring and Related Charges:

Global Restructuring Program

For the nine months ended January 31, 2024 and 2023, we recorded pretax restructuring charges of $50.9 million and $44.3 million, respectively, related to the Global Restructuring Program.

We anticipate ongoing severance related charges and facility-related costs associated with certain properties to result in additional restructuring charges in future periods.

See Note 9, “Restructuring and Related Charges” for more details on the Global Restructuring Program charges.

Business Optimization Program

For the nine months ended January 31, 2024 and 2023, we recorded pretax restructuring charges of $1.1 million and $0.9 million, respectively, related to this program.

These charges are reflected in Restructuring and related charges on our Unaudited Condensed Consolidated Statements of Net Loss.

For the impact of our restructuring programs on diluted loss per share, see the section below, “Diluted Loss per Share.”

Amortization of Intangible Assets:

Amortization of intangible assets was $42.7 million for the nine months ended January 31, 2024, a decrease of $22.7 million, or 35%, as compared with the prior year. On a constant currency basis, amortization of intangible assets decreased 35% as compared with the prior year primarily due to the cessation of amortization for held-for-sale assets and, to a lesser extent, the prior year period including $4.6 million due to the acceleration of expense related to the discontinued use of the mthree trademark, and the completion of amortization of certain acquired intangible assets. See Note 3, “Acquisitions and Divestitures” for more details on these held-for-sale assets.

Operating Loss, Adjusted Operating Income (OI) and Adjusted EBITDA:

Operating loss was $16.5 million for the nine months ended January 31, 2024 compared with the prior year loss of $26.6 million. The decrease was primarily due to lower costs of sales and, to a lesser extent, lower operating and administrative expenses, and a decrease in the amortization of intangible assets, partially offset by a decrease in revenue.

Adjusted OI on a constant currency basis and excluding restructuring charges, impairment of goodwill, legal settlement, the accelerated amortization of an intangible asset, and the adjusted contribution to profit for the Held for Sale or Sold segment decreased 14% as compared with the prior year. The decrease in Adjusted OI was primarily due to lower revenues, partially offset by a lower costs of sales and operating and administrative expenses.

Adjusted EBITDA on a constant currency basis decreased 7% as compared with the prior year primarily due to lower Adjusted OI.

Adjusted OI

Below is a reconciliation of our consolidated US GAAP Operating Loss to Non-GAAP Adjusted OI:

Nine Months Ended January 31, 2024 2023
US GAAP Operating Loss (16,521) (26,582)
Adjustments:
Restructuring and related charges 52,033 45,204
Impairment of goodwill 108,449 99,800
Legal settlement — 3,671
Accelerated amortization of an intangible asset (1) — 4,594
Held for Sale or Sold segment Adjusted Contribution to Profit (2) (26,302) 10,811
Non-GAAP Adjusted OI $117,659 $137,498

(1) We determined that a revision of the useful life of the mthree trademark was warranted and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022.

(2) Our Adjusted OI excludes the impact of our Held for Sale or Sold segment Adjusted Contribution to Profit.

56

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA:

Nine Months Ended January 31, 2024 2023
Net Loss $(225,584) $(51,111)
Interest expense 37,592 27,185
Benefit for income taxes (15,465) (1,397)
Depreciation and amortization 129,376 163,142
Non-GAAP EBITDA (74,081) 137,819
Impairment of goodwill 108,449 99,800
Legal settlement — 3,671
Restructuring and related charges 52,033 45,204
Foreign exchange losses (gains), including the write off of certain cumulative translation adjustments 3,489 (283)
Losses on sale of businesses and impairment charges related to assets held-for-sale 179,747 —
Other expense (income), net 3,700 (976)
Held for Sale or Sold segment Adjusted EBITDA (1) (29,739) (22,979)
Non-GAAP Adjusted EBITDA $243,598 $262,256

(1) Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA.

Interest Expense:

Interest expense for the nine months ended January 31, 2024, was $37.6 million compared with the prior year of $27.2 million. This increase was primarily due to a higher weighted average effective interest rate.

Foreign Exchange Transaction (Losses) Gains:

Foreign exchange transaction losses of $(3.5) million for the nine months ended January 31, 2024 were primarily due to losses on our foreign currency denominated third-party receivable and payable balances and, to a lesser extent, losses on our intercompany accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar. In fiscal year 2023, due to the closure of our operations in Russia, our Russian entity was deemed substantially liquidated. As a result, cumulative translation adjustments associated with that entity were recognized. In the nine months ended January 31, 2024, we wrote off an additional net $0.8 million in cumulative translation adjustments from our Russian entity.

Foreign exchange transaction gains of $0.3 million for the nine months ended January 31, 2023 were primarily due to losses on our foreign currency denominated third-party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Losses on Sale of Businesses and Impairment Charges Related to Assets Held-For-Sale:

For the nine months ended January 31, 2024, we recorded pretax losses on sale of businesses and impairment charges related to assets held-for-sale of $179.7 million.

The losses on sale of businesses is due to the sale of our University Services and Tuition Manager businesses previously in our Held for Sale or Sold segment, which resulted in a pretax loss of approximately $101.4 million and $1.5 million, respectively, during the nine months ended January 31, 2024.

Wiley Edge and CrossKnowledge continue to be reported as held-for-sale and these dispositions are expected to be completed by the first quarter of fiscal year 2025. We measured each disposal group at the lower of carrying value or fair value less cost to sell. We recorded a held-for-sale pretax impairment of $76.8 million, which includes $20.6 million for Wiley Edge and $56.2 million for CrossKnowledge during the nine months ended January 31, 2024. As noted above, on January 8, 2024 we entered into an agreement to sell our Wiley Edge business.

See Note 3, “Acquisitions and Divestitures” for more details on the divestitures and the held-for-sale businesses.

Benefit for Income Taxes:

Below is a reconciliation of our US GAAP Loss Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Nine Months Ended January 31, 2024 2023
US GAAP Loss Before Taxes $(241,049) $(52,508)
Pretax Impact of Adjustments:
Impairment of goodwill 108,449 99,800
Legal settlement — 3,671
Restructuring and related charges 52,033 45,204
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 1,089 906
Amortization of acquired intangible assets 44,550 68,611
Losses on sale of businesses and impairment charges related to assets held-for-sale 179,747 —
Held for Sale or Sold segment Adjusted Income Before Taxes (1) (28,253) (8,120)
Non-GAAP Adjusted Income Before Taxes $116,566 $157,564

(1) Our Adjusted Income Before Taxes excludes the Adjusted Income Before Taxes of our Held for Sale or Sold segment.

Below is a reconciliation of our US GAAP Income Tax Benefit to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Nine Months Ended January 31, 2024 2023
US GAAP Income Tax Benefit $(15,465) $(1,397)
Income Tax Impact of Adjustments (1):
Impairment of goodwill 2,697 4,857
Legal settlement — 716
Restructuring and related charges 13,237 11,159
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 112 274
Amortization of acquired intangible assets 8,668 14,811
Losses on sale of businesses and impairment charges related to assets held-for-sale 25,711 —
Held for Sale or Sold segment Adjusted Tax Provision (2) (6,518) (1,977)
Non-GAAP Adjusted Income Tax Provision $28,442 $28,443
US GAAP Effective Tax Rate 6.4% 2.7%
Non-GAAP Adjusted Effective Tax Rate 24.4% 18.1%

(1) For the nine months ended January 31, 2024, substantially all of the tax impact was from deferred taxes. For the nine months ended January 31, 2023, the tax impact was $5.5 million from current taxes and $24.3 million from deferred taxes.

(2) Our Adjusted Income Tax Provision excludes the Adjusted Tax Provision of our Held for Sale or Sold segment.

Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to tax attributes. The US GAAP effective tax rate for the nine months ended January 31, 2024, was 6.4% compared to 2.7% for the nine months ended January 31, 2023. The US GAAP effective tax rate for the nine months ended January 31, 2024, was greater than the US GAAP effective tax rate for the nine months ended January 31, 2023 primarily due to certain discrete items related to the filing of the consolidated federal income tax return for the year ended April 30, 2022 which resulted in a deferred tax benefit, the impact of US tax incentives, and other discrete items offset by the mix of non-US income. The impairment of goodwill resulting from the segment realignment described in Note 12, "Goodwill and Intangible Assets," results in a relatively small tax benefit of $2.7 million and losses on sale of businesses and impairment charges related to assets held-for-sale described in Note 3, "Acquisitions and Divestitures" results in a tax benefit of $25.7 million.

Excluding the $2.7 million tax benefit from the impairment of goodwill and $25.7 million tax benefit of the losses on sale of businesses and impairment charges related to assets held-for-sale, restructuring and other adjustments noted in the table above, the Non-GAAP adjusted effective tax rate was 24.4% for the nine months ended January 31, 2024, compared to 18.1% for the nine months ended January 31, 2023. The increase in the Non-GAAP adjusted effective tax rate for the nine months ended January 31, 2024, compared with the prior year ended January 31, 2023, was primarily due to the mix of non-US income offset by tax incentives in the US.

Diluted Loss per Share:

Diluted loss for the nine months ended January 31, 2024 was $(4.10) per share compared with diluted loss of $(0.92) per share for the nine months ended January 31, 2023. This decrease was primarily due to the losses on the sale of businesses, and the held-for-sale impairment charges in the nine months ended January 31, 2024 and, to a lesser extent, higher interest expense, partially offset by a higher benefit for income taxes in fiscal year 2024, and lower operating loss in fiscal year 2024.

Below is a reconciliation of our US GAAP Loss Per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below are presented in the section above, “Benefit for Income Taxes”.

Nine Months Ended January 31, 2024 2023
US GAAP Loss Per Share $(4.10) $(0.92)
Adjustments:
Impairment of goodwill 1.90 1.69
Legal settlement — 0.05
Restructuring and related charges 0.70 0.60
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 0.02 0.01
Amortization of acquired intangible assets 0.65 0.96
Losses on sale of businesses and impairment charges related to assets held-for-sale 2.77 —
Held for Sale or Sold segment Adjusted Net Income (1) (0.39) (0.11)
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) 0.04 0.01
Non-GAAP Adjusted EPS $1.59 $2.29

(1) Our Adjusted EPS excludes the Adjusted Net Income of our Held for Sale or Sold segment.

(2) Represents the impact of using diluted weighted-average number of common shares outstanding (55.6 million shares and 56.3 million shares for the nine months ended January 31, 2024 and 2023, respectively) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS decreased 29% primarily due to a decrease in Adjusted Operating Income, and to a lesser extent, higher interest expense and lower pension income.

SEGMENT OPERATING RESULTS

RESEARCH Revenue: Nine Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing $659,329 $685,884 (4)% (5)%
Research Solutions 112,344 113,988 (1)% (2)%
Total Research Revenue 771,673 799,872 (4)% (5)%
Cost of Sales 211,472 213,108 1% 2%
Operating Expenses 356,825 351,016 (2)% 0%
Amortization of Intangible Assets 33,895 35,009 3% 5%
Adjusted Contribution to Profit 169,481 200,739 (16)% (16)%
Depreciation and amortization 67,909 70,308 3% 4%
Adjusted EBITDA $237,390 $271,047 (12)% (13)%
Adjusted EBITDA Margin 30.8% 33.9%

Revenue:

Research revenue for the nine months ended January 31, 2024 decreased $28.2 million, or 4%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 5% as compared with the prior year primarily due to the carryover of the Hindawi publishing disruption experienced in fiscal year 2023. Additionally, to a lesser extent, revenues were unfavorably impacted by continued market softness in our corporate offerings. These impacts were partially offset by continued strong growth in our core open access publishing program. Excluding Hindawi, Research revenue was consistent with the prior year. Hindawi’s special issues program was suspended in the third quarter of fiscal year 2023 due to the presence in certain special issues of compromised articles. Open access article output declined 29% as compared with the prior year. Excluding Hindawi, open access article output growth was approximately 18% for the nine months ended January 31, 2024.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 13% as compared with the prior year. This decrease was primarily due to revenue performance as cost of sales declined and operating expenses were flat. Excluding Hindawi, Adjusted EBITDA decreased 1%. On a constant currency basis, Hindawi Adjusted EBITDA for the nine months ended January 31, 2024 decreased $31.9 million as compared with the prior year.

INDEX

LEARNING Revenue: Nine Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic $224,633 $223,826 0% 0%
Professional 179,961 178,713 1% 0%
Total Learning Revenue 404,594 402,539 1% 0%
Cost of Sales 105,685 110,280 4% 5%
Operating Expenses 207,026 218,341 5% 6%
Amortization of Intangible Assets 6,832 6,733 (1)% (1)%
Adjusted Contribution to Profit 85,051 67,185 27% 27%
Depreciation and amortization 41,338 42,445 3% 3%
Adjusted EBITDA $126,389 $109,630 15% 15%
Adjusted EBITDA Margin 31.2% 27.2%

Revenue:

Learning revenue for the nine months ended January 31, 2024 increased $2.1 million, or 1% as compared with the prior year on a reported basis. On a constant currency basis, revenue was consistent with the prior year. Academic revenue was consistent with the prior year due to a decrease in print book sales, offset by growth in digital courseware and, to a lesser extent, digital content. Professional revenue was consistent with the prior year due to a decrease in print and digital trade sales, offset by an increase in licensing revenue and professional assessments.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 15% as compared with the prior year. This increase was primarily due to lower print product related costs, a decrease in employee costs after recent restructuring actions and, to a lesser extent, a decrease in travel and entertainment expense.

INDEX

HELD FOR SALE OR SOLD Nine Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Held for Sale or Sold Revenue $228,259 $291,362 (22)% (23)%
Cost of Sales 139,220 194,996 29% 29%
Operating Expenses 60,734 88,245 31% 33%
Amortization of Intangible Assets 2,003 18,932 89% 91%
Adjusted Contribution to Profit 26,302 (10,811) # #
Depreciation and amortization 3,437 33,790 90% 90%
Adjusted EBITDA $29,739 $22,979 29% 28%
Adjusted EBITDA Margin 13.0% 7.9%

# Not meaningful

Revenue:

Held for Sale or Sold revenue for the nine months ended January 31, 2024 decreased $63.1 million, or 22%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 23% as compared with the prior year. This was due to declines in placement revenues, a decrease in University Services due to lower enrollments and the sale of the business on January 1, 2024 and, to a lesser extent, the disposition of certain businesses in the fourth quarter of fiscal year 2023 and in the first quarter of fiscal year 2024. For the nine months ended January 31, 2024, placements declined 51% and online enrollment declined 5%.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 28% as compared with the prior year. This increase was primarily due to lower cost of sales and operating expenses, partially offset by lower revenue. The lower cost of sales was due to lower placement costs, a decrease in marketing and employment costs in University Services due to restructuring actions and, to a lesser extent, the impact of the disposition of certain businesses in the fourth quarter of fiscal year 2023 and in fiscal year 2024.

CORPORATE EXPENSES Nine Months Ended January 31, 2024 2023 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Operating Expenses $136,873 $130,305 (5)% (4)%
Amortization of Intangible Assets — 121 # #
Adjusted Contribution to Profit (136,873) (130,426) (5)% (4)%
Depreciation and amortization 16,692 12,005 (39)% (39)%
Adjusted EBITDA $(120,181) $(118,421) (1)% (1)%

# Not meaningful

On a constant currency basis, adjusted corporate expenses of $120.2 million on an Adjusted EBITDA basis increased 1% as compared with the prior year. This was primarily due to lower incentive compensation accruals in the prior year, partially offset by lower marketing and occupancy costs.

LIQUIDITY AND CAPITAL RESOURCES

Principal Sources of Liquidity

We believe that our operating cash flow, together with our revolving credit facilities and other available debt financing, will be adequate to meet our operating, investing, and financing needs for at least the next twelve months. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used to fund shareholder dividends. Other discretionary uses of cash flow include share repurchases and acquisitions to complement our portfolio of businesses. As necessary, we may supplement operating cash flow with debt to fund these activities. The overall cash position of the Company reflects our durable business results and a global cash management strategy that considers liquidity management, economic factors and tax considerations. Our cash and cash equivalents are maintained at a number of financial institutions. To mitigate the risk of uninsured balances, we select financial institutions based on their credit ratings and financial strength, and we perform ongoing evaluations of these institutions to limit our concentration risk exposure to any financial institution.

As of January 31, 2024, we had cash and cash equivalents of $108.8 million, including cash and cash equivalents classified as held-for-sale of $15.7 million, of which approximately $107.1 million, or 98%, was located outside the US. Maintenance of these cash and cash equivalent balances outside the US does not have a material impact on the liquidity or capital resources of our operations. We intend to repatriate earnings from our non-US subsidiaries, and to the extent we repatriate these funds to the US, we will be required to pay income taxes in various US state and local jurisdictions and applicable non-US withholding or similar taxes in the periods in which such repatriation occurs. Accordingly, as of January 31, 2024, we have recorded a deferred tax liability of approximately $2.5 million related to the estimated taxes that would be incurred upon repatriating certain non-US earnings to the US.

On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). See Note 15, “Debt and Available Credit Facilities” for more details on the amendment. The Amended and Restated CA provided for senior unsecured credit facilities comprised of a (i) five-year revolving credit facility in an aggregate principal amount up to $1.115 billion, which matures November 2027, (ii) a five-year term loan A facility consisting of $200 million, which matures November 2027, and (iii) $185 million aggregate principal amount revolving credit facility through May 2024.

As of January 31, 2024, we had approximately $906.8 million of debt outstanding, net of unamortized issuance costs of $0.6 million, and approximately $587.4 million of unused borrowing capacity under our Amended and Restated CA and other facilities. Our Amended and Restated CA contains certain restrictive covenants related to our consolidated leverage ratio and interest coverage ratio, which we were in compliance with as of January 31, 2024.

Analysis of Historical Cash Flows

The following table shows the changes in our Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended January 31, 2024 and 2023.

Nine Months Ended January 31, 2024 2023
Net cash provided by operating activities $24,352 $53,718
Net cash used in investing activities (78,493) (80,072)
Net cash provided by financing activities 55,354 55,284
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash $432 $(2,670)

Cash flow from operations is seasonally a use of cash in the first half of Wiley’s fiscal year principally due to the timing of collections for annual journal subscriptions, which typically occurs in the beginning of the second half of our fiscal year.

Free cash flow less product development spending helps assess our ability, over the long term, to create value for our shareholders, as it represents cash available to repay debt, pay common dividends, and fund share repurchases, and acquisitions. Below are the details of Free cash flow less product development spending.

Free Cash Flow less Product Development Spending:

Nine Months Ended January 31, 2024 2023
Net cash provided by operating activities $24,352 $53,718
Less: Additions to technology, property and equipment (57,275) (57,616)
Less: Product development spending (12,324) (17,763)
Free cash flow less product development spending $(45,247) $(21,661)

Net Cash Provided by Operating Activities

The following is a summary of the $29.3 million change in Net cash provided by operating activities for the nine months ended January 31, 2024 compared with the nine months ended January 31, 2023 (amounts in millions).

Net cash provided by operating activities – Nine months ended January 31, 2023 $53.7
Net loss adjusted for items to reconcile net loss to net cash provided by operating activities, which would include such noncash items as depreciation and amortization, impairment of goodwill, losses on sale of businesses and impairment charges related to assets held-for-sale, restructuring charges, and the change in deferred taxes (41.4)
Working capital changes:
Accounts receivable, net and contract liabilities (18.9)
Accounts payable and accrued royalties (11.1)
Changes in other assets and liabilities 42.1
Net cash provided by operating activities – Nine months ended January 31, 2024 $24.4

The unfavorable change in accounts receivable, net and contract liabilities was primarily due to lower revenue, and the timing of invoicing and collections with customers.

The unfavorable change in accounts payable and accrued royalties was primarily due to the timing of payments.

The favorable changes in other assets and liabilities noted in the table above was primarily due to a decrease in employee-related costs, including lower payments for annual incentive compensation in fiscal year 2024 related to the prior fiscal year, partially offset by an increase in restructuring payments.

Our negative working capital (current assets less current liabilities) was $328.1 million and $354.3 million as of January 31, 2024 and April 30, 2023, respectively. This $26.2 million change in negative working capital was primarily due to the seasonality of our business. The primary driver of the negative working capital is the benefit realized from unearned contract liabilities related to subscriptions for which cash has been collected in advance. The contract liabilities will be recognized as income when the products are shipped or made available online to the customers over the term of the subscription. Current liabilities as of January 31, 2024 and as of April 30, 2023 includes $300.7 million and $504.7 million, respectively, primarily related to deferred subscription revenue for which cash was collected in advance.

Cash collected in advance for subscriptions is used by us for a number of purposes, including funding operations, capital expenditures, acquisitions, debt repayments, dividend payments, and share repurchases.

Net Cash Used In Investing Activities

Net cash used in investing activities for the nine months ended January 31, 2024 was $78.5 million compared to $80.1 million in the prior year. The decrease in cash used in investing activities was primarily due to a decrease in cash used of $5.4 million for product development spending, and a decrease of $2.7 million in cash used to acquire businesses, partially offset by an increase of $3.2 million for the acquisition of publication rights.

Net Cash Provided By Financing Activities

Net cash provided by financing activities was $55.4 million for the nine months ended January 31, 2024 compared to $55.3 million for the nine months ended January 31, 2023. This slight increase in cash provided by financing activities was primarily due to a decrease of $4.5 million in cash used for deferred financing costs in the nine months ended January 31, 2023, and a $4.0 million change from book overdrafts, offset by an increase in cash used to repurchase shares of $5.0 million, and lower net borrowings in the nine months ended January 31, 2024.

In the nine months ended January 31, 2024, we increased our quarterly dividend to shareholders to $1.40 per share annualized versus $1.39 per share annualized in the prior year.

The following table summarizes the shares repurchased of Class A and Class B Common Stock for the nine months ended January 31, 2024 and 2023 (shares in thousands):

Nine Months Ended January 31, 2024 2023
Shares repurchased – Class A 870 539
Shares repurchased – Class B 2 1
Average price – Class A and Class B $33.24 $44.47

66

Market risk

As filed, 6,359 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk primarily related to interest rates, foreign exchange, and credit risk. It is our policy to monitor these exposures and to use derivative financial investments and/or insurance contracts from time to time to reduce fluctuations in earnings and cash flows when it is deemed appropriate to do so. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rates

From time to time, we may use interest rate swaps, collars, or options to manage our exposure to fluctuations in interest rates. It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Interest Rate Contracts,” is incorporated herein by reference.

On an annual basis, a hypothetical one percent change in interest rates for the $357.4 million of unhedged variable rate debt as of January 31, 2024 would affect net income and cash flow by approximately $2.7 million.

Foreign Exchange Rates

Fluctuations in the currencies of countries where we operate outside the US may have a significant impact on financial results. We are primarily exposed to movements in British pound sterling, euros, Canadian and Australian dollars, and certain currencies in Asia. The statements of financial position of non-US business units are translated into US dollars using period-end exchange rates for assets and liabilities and the statements of income are translated into US dollars using weighted-average exchange rates for revenues and expenses.

Our significant investments in non-US businesses are exposed to foreign currency risk. Adjustments resulting from translating assets and liabilities are reported as a separate component of Accumulated other comprehensive loss, net of tax within Shareholders’ Equity under the caption Foreign currency translation adjustment.

During the three months ended January 31, 2024, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $25.1 million primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the nine months ended January 31, 2024, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $2.4 million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling, partially offset by fluctuations of the US dollar relative to the euro.

During the three months ended January 31, 2023, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $50.3 million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the nine months ended January 31, 2023, we recorded foreign currency translation (losses) in Accumulated other comprehensive loss, net of tax of approximately $(5.6) million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling, partially offset by fluctuations of the US dollar relative to the euro.

Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on the Unaudited Condensed Consolidated Statements of Net Loss as incurred. Under certain circumstances, we may enter into derivative financial instruments in the form of foreign currency forward contracts to hedge against specific transactions, including intercompany purchases and loans.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Foreign Currency Contracts,” is incorporated herein by reference.

Sales Return Reserves

The estimated allowance for print book sales returns is based upon historical return patterns, as well as current market trends in the businesses in which we operate. In connection with the estimated sales return reserves, we also include a related increase to inventory and a reduction to accrued royalties as a result of the expected returns.

The reserves are reflected in the following accounts of our Unaudited Condensed Consolidated Statements of Financial Position:

January 31, 2024 April 30, 2023
Increase in Inventories, net $7,718 $6,923
Decrease in Accrued royalties $(3,162) $(3,240)
Increase in Contract liabilities $25,851 $24,582
Print book sales return reserve net liability balance $(14,971) $(14,419)

A one percent change in the estimated sales return rate could affect net income by approximately $1.2 million. A change in the pattern or trends in returns could affect the estimated allowance.

Customer Credit Risk

In the journal publishing business, subscriptions are primarily sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity. Subscription agents account for approximately 15% of total annual consolidated revenue, and no one affiliated group of subscription agents accounts for more than 10% of total annual consolidated revenue.

Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online bookstore chains. No single book customer accounts for more than 7% of total consolidated revenue and 19% of accounts receivable at January 31, 2024. The top 10 book customers account for approximately 12% of total consolidated revenue and approximately 36% of accounts receivable at January 31, 2024.

Controls and procedures

As filed, 1,355 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s Chief Executive Officer and Chief Financial Officer, together with the Chief Accounting Officer and other members of the Company’s management, have conducted an evaluation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) during the quarter ended January 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 450 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2023, that if they were to occur, could materially adversely affect our businesses, consolidated financial condition, and results of operations. For a discussion of our risk factors, refer to Item 1A. “Risk Factors” contained in our annual report on Form 10-K for the fiscal year ended April 30, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-11-01 to 2024-01-31$460.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2023-05-01 to 2024-01-31$1.40bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-11-01 to 2024-01-31$143.7mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2023-05-01 to 2024-01-31$456.4mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2023-11-01 to 2024-01-31$253.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2023-05-01 to 2024-01-31$761.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-11-01 to 2024-01-31−$46.4mus-gaap:OperatingIncomeLoss
Operating income9 months2023-05-01 to 2024-01-31−$16.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-11-01 to 2024-01-31$13.3mus-gaap:InterestExpense
Interest expense9 months2023-05-01 to 2024-01-31$37.6mus-gaap:InterestExpense
Income tax3 months2023-11-01 to 2024-01-31$1.6mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2023-05-01 to 2024-01-31−$15.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-11-01 to 2024-01-31−$113.9mus-gaap:NetIncomeLoss
Net income9 months2023-05-01 to 2024-01-31−$225.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-11-01 to 2024-01-31−$2.08us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2023-05-01 to 2024-01-31−$4.10us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-11-01 to 2024-01-31−$2.08us-gaap:EarningsPerShareBasic
Basic EPS9 months2023-05-01 to 2024-01-31−$4.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-11-01 to 2024-01-3154,812,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2023-05-01 to 2024-01-3155,061,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2023-05-01 to 2024-01-31$24.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2023-05-01 to 2024-01-31$57.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2023-05-01 to 2024-01-31$57.9mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2023-05-01 to 2024-01-31$29.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-01-31$93.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-01-31$384.0mus-gaap:AssetsCurrent
Total assetsAt period end2024-01-31$2.71bnus-gaap:Assets
Current liabilitiesAt period end2024-01-31$712.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-01-31$1.96bnus-gaap:Liabilities
Long-term debtAt period end2024-01-31$900.5mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2024-01-31$6.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2024-01-31$748.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000107140-24-000029. Last ingested by Listed: Nov 10, 2026, 22:22 ET. Listed shows no prices and gives no investment advice.